REQUEST A DEMO
Total
USD $0.00
Search more companies

Baskhanbiopharma Inc. (South Korea)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Baskhanbiopharma Inc. Profile Updated: September 16, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Baskhanbiopharma Inc. is a company in South Korea, with a head office in Anseong. The company operates in the Pharmaceutical Preparation Manufacturing industry. It was established on October 16, 1986. The total number of employees is currently 114 (2025). The latest financial highlights indicate a net sales revenue increase of 16.18% in 2025. Over the same period, its total assets grew by 18.42%. In 2025, Baskhanbiopharma Inc.’s net profit margin increased by 4.52%.

Headquarters
354, Wondang-Ro, Wongok-Myeon
Anseong; Gyeonggi;

Contact Details: Purchase the Baskhanbiopharma Inc. report to view the information.

Website: http://www.baskhanbio.com

Basic Information
Total Employees:
Purchase the Baskhanbiopharma Inc. report to view the information.
Outstanding Shares:
Purchase the Baskhanbiopharma Inc. report to view the information.
Financial Auditors:
Purchase the Baskhanbiopharma Inc. report to view the information.
Incorporation Date:
October 16, 1986
Company Performance
Financial values in the chart are available after Baskhanbiopharma Inc. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
16.18%▲
Total Operating Revenue
15.22%▲
Operating Profit
87.26%▲
EBITDA
34.71%▲
Net Profit/Loss for the Period
70.39%▲
Total Assets
18.42%▲
Total Equity
19.65%▲
Operating Profit Margin
3.48%▲
Net Profit Margin
4.52%▲
Return on Equity (ROE)
3.93%▲
Debt / Equity
-0.26%▼
Quick Ratio
0.32%▲
Cash Ratio
-0.8%▼

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?